Please login to the form below

Not currently logged in
Email:
Password:

onartuzumab

This page shows the latest onartuzumab news and features for those working in and with pharma, biotech and healthcare.

Deaths cause Amgen to drop stomach cancer drug

Deaths cause Amgen to drop stomach cancer drug

Another drug acting via the HGF/SF:MET pathway - Roche/Genentech's onartuzumab - suffered a setback earlier this year although in this case the problem was a lack of efficacy in

Latest news

  • Roche drug fails in lung cancer trial Roche drug fails in lung cancer trial

    Damages prospects for onartuzumab. A phase III trial of Roche's cancer prospect onartuzumab has been abandoned after the drug failed to show efficacy. ... In a statement, Roche said it is evaluating the implications of the METLung study results across

More from news
Approximately 1 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Virgo Health

Virgo Health is an award-winning global healthcare communications and medical education agency comprising specialists with some of the best skills,...

Latest intelligence

From lay summaries to patient engagement programmes: how patient-centricity is finally becoming a reality
How pharma is progressing their commitment in patient engagement...
Cuttsy+Cuttsy awarded CPD Platinum by the IPA
Four years after being awarded Gold for their continuous professional development (CPD) Cuttsy+Cuttsy (C+C) have reached another milestone and been awarded Platinum accreditation....
Breaking Bad
Six behaviours separate the good brand teams from the bad...

Infographics